Related Experiment Videos
Endogenous dopaminergic tone and dopamine agonist action
S A Treseder1, L A Smith, P Jenner
1Neurodegenerative Disease Research Centre, Guy's, King's, and St. Thomas's School of Biomedical Sciences, King's College London, UK.
Movement Disorders : Official Journal of the Movement Disorder Society
|September 29, 2000
Summary
Dopamine receptor agonists' effectiveness in Parkinson's disease diminishes over time. This study shows that stimulating both D1 and D2 receptors is crucial for maximal therapeutic effects, even when dopamine production is reduced.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Dopamine receptor agonists offer early Parkinson's disease symptom relief.
- Agonist efficacy declines with disease progression, but the underlying mechanisms remain unclear.
- Maximal efficacy may depend on endogenous dopaminergic tone for D1 and D2 receptor stimulation.
Purpose of the Study:
- Investigate the impact of tyrosine hydroxylase inhibition on dopamine agonist and levodopa efficacy.
- Determine the necessity of endogenous dopaminergic tone for antiparkinsonian effects.
Main Methods:
- Utilized a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model in common marmosets.
- Administered alpha-methyl-p-tyrosine (AMPT), a tyrosine hydroxylase inhibitor, to reduce dopamine synthesis.
- Assessed the effects of D1, D2, and mixed D1/D2 agonists, as well as levodopa, with and without AMPT pretreatment on motor function and activity.
Main Results:
- AMPT alone exacerbated motor deficits and reduced locomotor activity.
- Levodopa effectively reversed motor deficits regardless of AMPT pretreatment.
- D1 and D2 agonists reversed motor deficits, but their effects were significantly inhibited by AMPT.
- Combined D1/D2 agonist administration and apomorphine showed greater resistance to AMPT than individual agonists, yet were still affected.
- AMPT's impact suggests potential roles for endogenous L-dopa and norepinephrine in motor activity.
Conclusions:
- Maximal antiparkinsonian response to dopamine receptor agonists requires stimulation of both D1 and D2 receptors.
- Reduced tyrosine hydroxylase activity impacts motor function beyond just dopamine synthesis, potentially involving norepinephrine pathways.